Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/153872 |
Resumo: | Overconsumption of alcohol leads to alcoholic liver disease (ALD). Natural compounds have been investigated previously for their hepatoprotective activities against liver injury. This study investigated the protective effect of Alhagi sparsifolia on ALD. Alcohol was administered to mice for three consecutive days; either alone or in combination with Alhagi sparsifolia extract (150, 300, 600 mg/kg). Serum aspartate aminotransferase and alanine transaminase as biomarkers of liver injury, the content of malonaldehyde, hydrogen peroxide (H2O2) and glutathione which indicated the redox status of liver and the antioxidant enzyme activity of super oxide dismutase were detected, respectively. Moreover, the expression of protein cytochrome P450 2E1 (CYP2E1) the key enzyme of alcohol metabolism, and also tested by western blot experiment. Subsequently, the mRNA levels of inflammatory factors including TNF- α and TLR4 was determined real-time PCR. Results showed that Alhagi sparsifolia significantly alleviated alcohol-induced liver injury by reducing serum ALT and AST, inhibiting MDA and H2O2 content, increasing SOD, and GSH level in the liver (P< 0.05). In addition, the Alhagi sparsifolia treatment inhibited the expression of CYP2E1 (P< 0.05). The results suggest that Alhagi sparsifolia could be a promising natural substance for ameliorating acute alcohol-induced oxidative stress and hepatic injury. |
id |
USP-31_9be354cbc5941b28e03ac9d3c368c500 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/153872 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in miceAlcoholic liver diseaseAlhagi sparsifoliaHepatoprotective effectAntioxidantionCYP2E1Overconsumption of alcohol leads to alcoholic liver disease (ALD). Natural compounds have been investigated previously for their hepatoprotective activities against liver injury. This study investigated the protective effect of Alhagi sparsifolia on ALD. Alcohol was administered to mice for three consecutive days; either alone or in combination with Alhagi sparsifolia extract (150, 300, 600 mg/kg). Serum aspartate aminotransferase and alanine transaminase as biomarkers of liver injury, the content of malonaldehyde, hydrogen peroxide (H2O2) and glutathione which indicated the redox status of liver and the antioxidant enzyme activity of super oxide dismutase were detected, respectively. Moreover, the expression of protein cytochrome P450 2E1 (CYP2E1) the key enzyme of alcohol metabolism, and also tested by western blot experiment. Subsequently, the mRNA levels of inflammatory factors including TNF- α and TLR4 was determined real-time PCR. Results showed that Alhagi sparsifolia significantly alleviated alcohol-induced liver injury by reducing serum ALT and AST, inhibiting MDA and H2O2 content, increasing SOD, and GSH level in the liver (P< 0.05). In addition, the Alhagi sparsifolia treatment inhibited the expression of CYP2E1 (P< 0.05). The results suggest that Alhagi sparsifolia could be a promising natural substance for ameliorating acute alcohol-induced oxidative stress and hepatic injury.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-11-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15387210.1590/s2175-97902018000317732Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 3 (2018); e17732Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 3 (2018); e17732Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 3 (2018); e177322175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/153872/150222Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessMaimaitimin, KuerbanjiangJiang, ZhihuiAierken, AiliShayibuzhati, MikeremuZhang, Xiaoying2019-03-17T13:19:35Zoai:revistas.usp.br:article/153872Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-03-17T13:19:35Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
title |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
spellingShingle |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice Maimaitimin, Kuerbanjiang Alcoholic liver disease Alhagi sparsifolia Hepatoprotective effect Antioxidantion CYP2E1 |
title_short |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
title_full |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
title_fullStr |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
title_full_unstemmed |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
title_sort |
Hepatoprotective effect of Alhagi sparsifolia against Alcoholic Liver injury in mice |
author |
Maimaitimin, Kuerbanjiang |
author_facet |
Maimaitimin, Kuerbanjiang Jiang, Zhihui Aierken, Aili Shayibuzhati, Mikeremu Zhang, Xiaoying |
author_role |
author |
author2 |
Jiang, Zhihui Aierken, Aili Shayibuzhati, Mikeremu Zhang, Xiaoying |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Maimaitimin, Kuerbanjiang Jiang, Zhihui Aierken, Aili Shayibuzhati, Mikeremu Zhang, Xiaoying |
dc.subject.por.fl_str_mv |
Alcoholic liver disease Alhagi sparsifolia Hepatoprotective effect Antioxidantion CYP2E1 |
topic |
Alcoholic liver disease Alhagi sparsifolia Hepatoprotective effect Antioxidantion CYP2E1 |
description |
Overconsumption of alcohol leads to alcoholic liver disease (ALD). Natural compounds have been investigated previously for their hepatoprotective activities against liver injury. This study investigated the protective effect of Alhagi sparsifolia on ALD. Alcohol was administered to mice for three consecutive days; either alone or in combination with Alhagi sparsifolia extract (150, 300, 600 mg/kg). Serum aspartate aminotransferase and alanine transaminase as biomarkers of liver injury, the content of malonaldehyde, hydrogen peroxide (H2O2) and glutathione which indicated the redox status of liver and the antioxidant enzyme activity of super oxide dismutase were detected, respectively. Moreover, the expression of protein cytochrome P450 2E1 (CYP2E1) the key enzyme of alcohol metabolism, and also tested by western blot experiment. Subsequently, the mRNA levels of inflammatory factors including TNF- α and TLR4 was determined real-time PCR. Results showed that Alhagi sparsifolia significantly alleviated alcohol-induced liver injury by reducing serum ALT and AST, inhibiting MDA and H2O2 content, increasing SOD, and GSH level in the liver (P< 0.05). In addition, the Alhagi sparsifolia treatment inhibited the expression of CYP2E1 (P< 0.05). The results suggest that Alhagi sparsifolia could be a promising natural substance for ameliorating acute alcohol-induced oxidative stress and hepatic injury. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-11-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/153872 10.1590/s2175-97902018000317732 |
url |
https://www.revistas.usp.br/bjps/article/view/153872 |
identifier_str_mv |
10.1590/s2175-97902018000317732 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/153872/150222 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 3 (2018); e17732 Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 3 (2018); e17732 Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 3 (2018); e17732 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222913815642112 |